Cargando…
Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020
Autores principales: | Essa, Mohammed, Ross, Joseph S., Dhruva, Sanket S., Desai, Nihar R., Yeh, Robert W., Faridi, Kamil F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227267/ https://www.ncbi.nlm.nih.gov/pubmed/37042289 http://dx.doi.org/10.1161/JAHA.122.028869 |
Ejemplares similares
-
Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020
por: Kyle, Michael Anne, et al.
Publicado: (2022) -
Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021) -
Development and Testing of Improved Models to Predict Payment Using Centers for Medicare & Medicaid Services Claims Data
por: Krumholz, Harlan M., et al.
Publicado: (2019) -
The impact of Medicaid expansion on spending and utilization by older low‐income Medicare beneficiaries
por: Mellor, Jennifer M., et al.
Publicado: (2023) -
Trends in Use of and Medicare Spending on Short-Course Radiotherapy for Lymphomas From 2015 to 2019
por: Tringale, Kathryn R., et al.
Publicado: (2022)